Ekso Bionics Holdings, Inc. (EKSO) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -2.12M | -4.33M | -2.06M | -3.44M | -1.97M | -1.43M | -2.28M | -2.67M | -3.47M | -1.58M | -3.35M | -2.9M |
| Operating CF Margin % | -99.16% | -137.93% | -48.76% | -167.43% | -58.22% | -28.15% | -55.15% | -53.94% | -92.28% | -32.68% | -72.78% | -61.73% |
| Operating CF Growth % | -8.04% | -202.23% | 9.49% | -28.99% | 43.31% | 9.53% | 32.09% | 8.03% | 17.75% | 56.53% | -29.46% | 31.66% |
| Net Income | -6.88M | -4.67M | -1.42M | -2.71M | -2.89M | -3.41M | -2.07M | -2.42M | -3.43M | -3.21M | -3.37M | -4.23M |
| Depreciation & Amortization | 454K | 451K | 367K | 377K | 378K | 398K | 407K | 397K | 406K | 675K | 342K | 267K |
| Stock-Based Compensation | 114K | 758K | 259K | 207K | 225K | 387K | 470K | 368K | 405K | 553K | 526K | 640K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -382K | 382K | 0 |
| Other Non-Cash Items | 4.19M | 629K | 22K | -1.31M | -427K | 1.22M | -614K | 58K | 104K | -130K | 82K | 31K |
| Working Capital Changes | 0 | -1.5M | -1.29M | -5K | 750K | -28K | -468K | -1.08M | -952K | 914K | -1.32M | 389K |
| Change in Receivables | 2.42M | -1.1M | -1.51M | 2.15M | 900K | -540K | -398K | -815K | -214K | 140K | -830K | -316K |
| Change in Inventory | 168K | 112K | 494K | -502K | -379K | 337K | -71K | 71K | -80K | 394K | 121K | 92K |
| Change in Payables | 679K | -232K | 216K | -565K | 444K | -247K | -322K | 249K | 32K | -660K | -634K | 97K |
| Cash from Investing | 0 | -126K | -12K | -40K | -10K | -21K | -8K | 0 | -8K | -43K | -17K | -55K |
| Capital Expenditures | 0 | -50K | 50K | -40K | -10K | -21K | -8K | 0 | -8K | -43K | -17K | -55K |
| CapEx % of Revenue | - | 1.59% | 1.18% | 1.94% | 0.3% | 0.41% | 0.19% | - | 0.21% | 0.89% | 0.37% | 1.17% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -76K | -62K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 4.95M | 2.92M | -437K | 616K | 3.53M | -314K | 4.69M | -265K | 3.66M | 348K | 0 | 0 |
| Debt Issued (Net) | 0 | -311K | -389K | -312K | -313K | -312K | -313K | -312K | -313K | -313K | 0 | 0 |
| Equity Issued (Net) | 0 | -624K | -48K | 928K | 3.84M | -2K | 5M | 47K | 3.97M | 661K | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | -226K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 4.95M | 3.86M | 0 | 0 | 226K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 2.82M | -1.55M | -2.52M | -2.81M | 1.56M | -1.8M | 2.41M | -2.91M | 161K | -1.3M | -3.37M | -2.97M |
| Free Cash Flow | -2.12M | -4.38M | -2.01M | -3.44M | -1.97M | -1.45M | -2.29M | -2.67M | -3.47M | -1.63M | -3.37M | -2.96M |
| FCF Margin % | -99.16% | -139.52% | -47.58% | -167.43% | -58.22% | -28.57% | -55.34% | -53.94% | -92.49% | -33.57% | -73.15% | -62.9% |
| FCF Growth % | -8.04% | -201.31% | 11.99% | -28.99% | 43.44% | 10.63% | 32.2% | 9.74% | 18.37% | 55.99% | -23.4% | 30.37% |
| FCF per Share | -0.60 | -1.81 | -0.77 | -1.58 | -0.08 | -0.06 | -0.11 | -0.15 | -0.20 | -0.11 | -0.24 | -0.22 |
| FCF Conversion (FCF/Net Income) | 0.31x | 0.93x | 1.45x | 1.27x | 0.68x | 0.42x | 1.10x | 1.11x | 1.01x | 0.49x | 1.00x | 0.69x |
| Interest Paid | 0 | 0 | 0 | 42K | 0 | 40K | 46K | 48K | 0 | 46K | 47K | 0 |
| Taxes Paid | 0 | 0 | 0 | 4K | 0 | -1K | 1K | 8K | 0 | 12K | 1K | 0 |